Cargando…
Bi-Centric Independent Validation of Outcome Prediction after Radioembolization of Primary and Secondary Liver Cancer
Background: Yttrium-90 radioembolization (RE) plays an important role in the treatment of liver malignancies. Optimal patient selection is crucial for an effective and safe treatment. In this study, we aim to validate the prognostic performance of a previously established random survival forest (RSF...
Autores principales: | Fabritius, Matthias Philipp, Seidensticker, Max, Rueckel, Johannes, Heinze, Constanze, Pech, Maciej, Paprottka, Karolin Johanna, Paprottka, Philipp Marius, Topalis, Johanna, Bender, Andreas, Ricke, Jens, Mittermeier, Andreas, Ingrisch, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396945/ https://www.ncbi.nlm.nih.gov/pubmed/34441964 http://dx.doi.org/10.3390/jcm10163668 |
Ejemplares similares
-
Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization
por: Seidensticker, Max, et al.
Publicado: (2021) -
Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma—An Evaluation of Predictors
por: Paprottka, Karolin J., et al.
Publicado: (2021) -
The Impact of Unilateral (90)Y-radioembolization on Functional Changes in the Contralateral Hepatic Lobe: The Prospective, Open-label RadioEmbolization, Volumetry, and Liver FuncTion Measurements (REVoluTion) Study
por: Garlipp, Benjamin, et al.
Publicado: (2021) -
Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival
por: Seidensticker, Ricarda, et al.
Publicado: (2018) -
Overview of Ongoing Clinical Trials on Radioembolization
por: Fabritius, Matthias P., et al.
Publicado: (2022)